Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization

Autor: Phillip D. Markham, Pranab K. Chanda, Robert J. Natuk, Maria Myagkikh, Mark R. Wade, Narender K. Kalyan, Alan R. Davis, Susan Zolla-Pazner, Shabnam Alipanah, Shri C.S. Murthy, Larry O. Arthur, Robert C. Gallo, Kathy Steimer, Marjorie Robert-Guroff, Satoshi Mizutani, Marvin S. Reitz, Faruk Sinangil, Stephen M. Nigida, Michael D. Lubeck, Jorg Eichberg, Kristine Aldrich, Paul P. Hung
Rok vydání: 1997
Předmět:
Zdroj: Nature Medicine. 3:651-658
ISSN: 1546-170X
1078-8956
DOI: 10.1038/nm0697-651
Popis: A combination AIDS vaccine approach consisting of priming with adenovirus-HIV-1MN gp160 recombinants followed by boosting with HIV-1SF2 gp120 was evaluated in chimpanzees. Long-lasting protection, requiring only three immunizations, was achieved against a low-dose challenge with the SF2 strain of HIV-1 and a subsequent high-dose SF2 challenge administered 1 year later without an intervening boost. Notably, neutralizing antibody responses against both clinical and laboratory isolates developed in three chimpanzees and persisted until the time of high-dose challenge. The possibility that cytotoxic T-lymphocytes contribute to low-dose protection of a chimpanzee lacking neutralizing antibodies is suggested. Our results validate the live vector priming/subunit booster approach and should stimulate interest in assessing this combination vaccine approach in humans.
Databáze: OpenAIRE